Recent advances in transdermal drug delivery

Archives of Pharmacal Research

Volumn 33, Issue 3, 2010, Pages 339-351

  Subedi, Robhash Kusam ^a   Oh, Seaung Youl ^b   Chun, Myung Kwan ^a   Choi, Hoo Kyun ^a  

^a Chosun University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

Adhesion; Crystallization; Matrix system; Permeation enhancers; Pressure sensitive adhesive; Transdermal drug delivery

Indexed keywords

ACRYLIC ACID; ADHESIVE AGENT; BUPRENORPHINE; BUTRANS; CAPSAICIN; CATAPRESS TTS; CEFALEXIN; CLONIDINE; DICLOFENAC; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTRAN; FEMATRIX; FENTANYL; GLYCERYL TRINITRATE; GRANISETRON; KETOPROFEN; KETOROLAC; KETOTOP; LIDOCAINE; MATRIFEN; METHYLPHENIDATE; NAPROXEN; NICOSTOP; NICOTINE; NUPATCH; NUVELLE TS; ORTHOEVRA; OXYBUTYNIN; PIROXICAM; PRODRUG; QUTENZA; RHEUMASTOP; RIVASTIGMINE; ROTIGOTINE; RUBBER; SANSUCO; SCOPOLAMINE; SELEGILINE; SILICONE; SYNERA; TESTODERMTTS; TESTOSTERONE; TRAST; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG; TISSUE ADHESIVE;

ADHESION; ALZHEIMER DISEASE; ANGINA PECTORIS; ATTENTION DEFICIT DISORDER; BLADDER DISEASE; CRYSTALLIZATION; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; ECHOGRAPHY; ELECTRICITY; ELECTROPORATION; HUMAN; HYPERTENSION; HYPOGONADISM; INFLAMMATION; IONTOPHORESIS; MOTION SICKNESS; NAUSEA; NONHUMAN; PAIN; PARKINSON DISEASE; POSTHERPETIC NEURALGIA; REVIEW; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION; VOMITING; ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG DOSAGE FORM; DRUG EFFECT; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY; PRESSURE; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PRESSURE; SKIN; SKIN ABSORPTION; TISSUE ADHESIVES;

EID: 77953631852     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0301-7     Document Type: Review

References (85)

1. Akimoto, T., Kawahara, K., Nagase Y., and Aoyagi, T., The enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group. J. Control. Release, 77, 49-57 (2001).
2. ®) in vitro: Dependency on needle size and applied formulation. Eur. J. Pharm. Sci., 36, 511-523 (2009).
3. Barry, B. W., Mode of action of penetration enhancers in human skin. J. Control. Release, 6, 85-97 (1987).
4. Barry, B. W., Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci., 14, 101-114 (2001).
5. Benson, H. A. E., Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv., 2, 23-33 (2005).
6. Burnette, R. R., and Ongpipattanakul, B., Characterization of the permselective properties of excised human skin during Iontophoresis. J. Pharm. Sci., 76, 765-773 (1987).
7. Cheong, H.-A., and Choi, H.-K., Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. Pharm. Res., 19, 1375-1380 (2002).
8. Cheong, H.-A., and Choi, H.-K., Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix. Eur. J. Pharm. Sci., 18, 149-153 (2003).
9. Cho, Y.-J. and Choi, H.-K., Enhancement of percutaneous absorption of ketoprofen: Effect of vehicles and adhesive matrix. Int. J. Pharm., 169, 95-104 (1998).
10. Choi, A., Gang, H., Chun, I., and Gwak, H., The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin. Int. J. Pharm., 357, 126-131 (2008).
11. Choi, H.-K., Flynn, G. L., and Amidon, G. L., Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH and inhibitors on enkephalin transport. Pharm. Res., 7, 1099-1106 (1990).
12. Chun, M.-K. and Choi, H.-K., Transdermal delivery of estradiol and norethindrone acetate: Effect of vehicles and pressure sensitive adhesive matrix. J. Kor. Pharm. Sci., 35, 173-177 (2005).
13. Denet, A. R. and Préat, V., Transdermal delivery of timolol by electroporation through human skin. J. Control. Release, 88, 253-262 (2003).
14. Denet, A.-R., Vanbever, R., and Preat V., Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev., 56, 659-674 (2004).
15. Doh, H.-J., Cho, W.-J., Young, C.-S., Choi, H.-G., Kim, J. S., Lee, C.-H., Kim, D.-D., Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J. Pharm. Sci., 92, 1008-1017 (2003).
16. Drakulic, B. J., Juranic, I. O., Eric, S., and Zloh, M., Role of complexes formation between drugs and penetration enhancers in transdermal delivery. Int. J. Pharm., 363, 40-49 (2008).
17. El-laithy, H. M., Novel transdermal delivery of fimolol maleate using sugar esters: Preclinical and clinical studies. Eur. J. Pharm. Biopharm., 72, 239-245 (2009).
18. Funke, A. P., Gunther, C., Muller, R. H., and Lipp, R., Invitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS. J. Control. Release, 82, 63-70 (2002).
19. Furuishi, T., Oda, S., Saito, H., Fukami, T., Suzuki, T., and Tomono, K., Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine. Biol. Pharm. Bull., 30, 1350-1353 (2007).
20. Green, P. G., Hinz, R. S., Cullander, C., Yamane, G., and Guy, R. H., Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res., 8, 1113-1120 (1991).
21. Guillard, E.C., Tfayli, A., Laugel, C., and Guffroy, A. B., Molecular interactions of penetration enhancers within ceramides organization: A FTIR approach. Eur. J. Pharm. Sci., 36, 192-199 (2009).
22. Guy, R. H., Kalia, Y. N., Delgado-Charro, M. B., Merino, V., Lopez, A., and Marro, D., Iontophoresis: Electrorepulsion and electroosmosis. J. Control. Release, 64, 129-132 (2000).
23. Gwak H. S. and Chun I. K., Effect of vehicles and enhancers on the in vitro skin penetration of aspalatone and its enzymatic degradation across rat skins. Arch. Pharm. Res., 24, 572-577 (2001).
24. Gwak, H. S., Oh, S. O., and Chun, I. K., In vitro percutaneous absorption of ondansetron hydrochloride from pressure sensitive adhesive matrices through hairless mouse skin. Arch. Pharm. Res., 26, 644-648 (2003).
25. Hai, N. T., Kim, J., Park, E.-S., and Chi, S.-C., Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. Int. J. Pharm., 357, 55-60 (2008).
26. Hatanaka, T., Kamon, T., Morigaki, S., Katayama, K., and Koizumi, T., Ion pair skin transport of a zwitterionic drug, cephalexin. J. Control. Release, 66, 63-71 (2000).
27. Hatfield, S. F., Hot melt pressure sensitive adhesives. US Patent 7, 442, 739 (2008).
28. Henry, S., McAllister, D. V., Allen, M. G., and Prausnitz, M. R., Microfabricated microneedles: A novel approach to transdermal drug delivery. J. Pharm. Sci., 87, 922-925 (1998). (Pubitemid 28381247)
29. Hirvonen, J., and Guy, R. H., Iontophoretic delivery across the skin: Electroosmosis and its modulation by drug substances. Pharm. Res., 14, 1258-1263 (1997).
30. Hirvonen, J., Kalia, Y. N., and Guy, R. H., Transdermal delivery of peptides by Iontophoresis. Nat. Biotechnol., 14, 1710-1713 (1996).
31. Ho, K. Y. and Dodou, K., Rheological studies on pressuresensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance. Int. J. Pharm., 333, 24-33 (2007).
32. Jesus, M. and Steven, S., Solubility parameter based drug delivery system and method for altering drug saturation concentration. US Patent 5, 474, 783 (1995).
33. Jesus, M. and Steven, S., Solubility parameter based drug delivery system and method for altering drug saturation concentration. US Patent 5, 656, 286 (1997).
34. Kalia, Y. N., Naik, A., Garrison, J., and Guy, R. H., Iontophoretic drug delivery. Adv. Drug Deliv. Rev., 56, 619-658 (2004).
35. Karande, P., Jain, A., Ergun, K., Kispersky, V., and Mitragotri, S., Design principles of chemical penetration enhancers for transdermal drug delivery. Proc. Natl. Acad. Sci. USA, 102, 4688-4693 (2005).
36. Kim, J.-H., Cho, Y.-J., and Choi, H.-K., Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin. Int. J. Pharm., 196, 105-113 (2000).
37. Kim, B.-D. and Choi, H.-K., Penetration enhancement of β2- selective agonist, tulobuterol, across hairless mouse skin. J. Kor. Pharm. Sci., 33, 79-84 (2003).
38. Kim, J.-H. and Choi, H.-K., Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int. J. Pharm., 236, 81-85 (2002).
39. Kim, J.-H., Lee, C. H., and Choi, H.-K., Transdermal delivery of physostigmine: Effects of enhancers and pressuresensitive adhesives. Drug Dev. Ind. Pharm., 28, 833-839 (2002).
40. Kotiyan, P. N. and Vavia, P. R., Eudragits: Role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol. Eur. J. Pharm. Biopharm., 52, 173-180 (2001).
41. Lee, I. S. P., Stock for labels and tapes utilizing siliconized emulsion based pressure-sensitive adhesives. US Patent 5,234,736 (1993).
42. Lee, C. A.-R. and Moon, H. K., Gravimetric analysis and differential scanning calorimetric studies on glycerininduced skin hydration. Arch. Pharm. Res., 30, 1489-1495 (2007).
43. Marro, D., Kalia, Y. N., Begona Delgado-Charro, M., and Guy, R. H., Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res., 18, 1701-1708 (2001).
44. Mayer, A. and Keller, P., Water resistant, removable acrylic emulsion pressure sensitive adhesive. US Patent 5,420,195 (1995).
45. Merino, G., Kalia, Y. N., Delgado-Charro, M. B., Potts, R. O., and Guy, R. H., Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J. Control. Release, 88, 85-94 (2003).
46. Mitragotri, S., Breaking the skin barrier. Adv. Drug Deliv. Rev., 56, 555-556 (
47. Mitragotri, S., Innovation: Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov., 4, 255-260 (2005).
48. Mitragotri, S. and Kost, J., Low-frequency sonophoresis: a noninvasive method of drug delivery and diagnostics. Biotechnol. Prog., 16, 488-492 (2000).
49. Myoung, Y. and Choi, H.-K., Effects of vehicles and pressure sensitive adhesives on the penetration of isosorbide dinitrate across the hairless mouse skin. Drug Deliv., 9, 121-126 (2002).
50. Naik, A., Kalia Y. N., and Guy R. H., Transdermal drug delivery: Overcoming the skin's barrier function. Pharm. Sci. Technol. Today, 3, 318-326 (2000).
51. Ogura, M., Paliwal, S., and Mitragotri, S., Low-frequency sonophoresis: Current status and future prospects. Adv. Drug Deliv. Rev., 60, 1218-1223 (2008).
52. Panchagnula, R., Pillai, O., Nair, V. B., and Ramarao, P., Transdermal Iontophoresis revisited. Curr. Opin. Chem. Biol., 4, 468-473 (2000).
53. Park, E.-S., Chang, S.-Y., Hahn, M., and Chi, S.-C., Enhancing effect of polyoxyethylene alkyl ethers on the skin ermeation of ibuprofen. Int. J. Pharm., 209, 109-119 (2000).
54. Park, S.-C. and Choi, H.-K., Development of transdermal drug delivery system for the combination of physostigmine and procyclidine. J. Kor. Pharm. Sci., 31, 181-184 (2001).
55. Peterson, T., Burton, S., and Ferber, R., In vitro permeability of poly (ethylene-vinyl acetate) and microporous polyethylene membranes. Proceed. Inter. Sym. Control. Release Bioact. Mater., 17, 411 (1990).
56. Potts, R. O. and Guy, R. H., Predicting skin permeability. Pharm. Res., 9, 663-669 (1992).
57. Prausnitz, M. R., Do high-voltage pulses cause changes in skin structure? J. Control. Release, 40, 321-326 (1996).
58. Prausnitz, M. R., Edelman, E. R., Gimm, J. A., Langer, R., and Weaver, J. C., Transdermal delivery of heparin by skin electroporation. Biol. Technol., 13, 1205-1209 (1995).
59. Prausnitz, M. R., Bose, V. G., Langer, R., and Weaver, J. C., Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA, 90, 10504-10508 (1993).
60. Prausnitz, M. R. and Langer, R., Transdermal drug delivery. Nat. Biotechnol., 26, 1261-1268 (2008).
61. Qvist, M. H., Hoeck, U., Kreilgaard, B., Madsen, F., and Frokjaer, S., Release of chemical permeation enhancers from drug-in-adhesive transdermal patches. Int. J. Pharm., 231, 253-263 (2002).
62. Raghavan, S. L., Trividic, A., Davis, A. F., and Hadgraft, J., Crystallization of hydrocortisone acetate: Influence of polymers. Int. J. Pharm., 212, 213-221 (2001).
63. Rautio, J., Nevalainen, T., Taipale, H., Vepsalainen, J., Gynther, J., Pedersen, T., and Jarvinen, T., Synthesis and in vitro evaluation of aminoacyloxyalkyl esters of 2-(6-methoxy-2-naphthyl) propionic acid as novel naproxen prodrugs for dermal drug delivery. Pharm. Res., 16, 1172-1178 (1999).
64. Raynaud, J.-P., Auges, M., Liorzou, L., Turlier, V., and Lauze, C., Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions. Int. J. Pharm., 375, 28-32 (2009).
65. Ren, C., Fang, L., Li, T., Wang, M., Zhao, L., and He, Z., Effect of permeation enhancers and organic acids on the skin permeation of Indapamide. Int. J. Pharm., 350, 43-47 (2008).
66. Ren, C., Fang, L., Ling, L., Wang, Q., Liu, S., Zhao, L., and He, Z., Design and in vivo evaluation of an Indapamide transdermal patch. Int. J. Pharm., 370, 129-135 (2009).
67. Roderick B. W. and Eric W. S., The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev., 18, 295-301 (1996).
68. Russell, T. E., Pressure-sensitive hot-melt adhesives. US Patent 3,862,068 (1975).
69. Satas, D., Handbook of pressure sensitive adhesive technology. Van Nostrand Reinhold, New York, 1989).
70. Scheindlin, S., Transdermal drug delivery: Past, present, future. Mol. Interv., 4, 308-312 (2004).
71. Sloan, K. B. and Wasdo, S., Designing for topical delivery: Prodrugs can make the difference. Med. Res. Rev., 23, 763-793 (2003).
72. Suh, E.-J., Woo, Y.-A., and Kim, H.-J., Determination of water content in skin by using a FT near infrared spectrometer. Arch. Pharm. Res., 28, 458-462 (2005).
73. Taghizadeh, S. M., Mirzadeh, H., Barikani, M., and Yousefi, M., Miscibility and tack of blends of poly(vinylpyrrolidone) /acrylic pressure-sensitive adhesive. Int. J. Adhes. Adhes., 29, 302-308 (2009).
74. Tan, H. S. and Pfister, W. R., Pressure-sensitive adhesivesfor transdermal drug delivery systems. Pharm. Sci. Technol. Today, 2, 60-69 (1999).
75. Tobing, S. D., Klein, A., and White, T. E., Adhesives and method of making same. US Patent 6, 608,134 (2003).
76. Vanbever, R., Langers, G., Montmayeur, S., and Preat, V., Transdermal delivery of fentanyl: Rapid onset of analgesia using skin electroporation. J. Control. Release, 50, 225-235 (1998).
77. Van Buskirk, G. A., Gonzalez, M. A., Shah, V. P., Barnhardt, S., Barrett, C., Berge, S., Cleary, G., Chan, K., Flynn, G., Foster, T., Gale, R., Garrision, R., Gochnour, S., Gotto, A., Govil, S., Gray, V. A., Hammar, J., Harder, S., Hoiberg, C., Hussain, A., Karp, C., Mantelle, H. L. J., Noonan, P., Swanson, D., and Zerbe, Horst. Scale-up of adhesive transdermal drug delivery systems. Eur. J. Pharm. Biopharm., 44, 327-331 (1997). (Pubitemid 28298768)
78. Vanbever, R., Leroy, M.-A., and Pré at, V., Transdermal permeation of neutral molecules by electroporation. J. Control. Release, 54, 243-250 (1998).
79. Venkatraman, S. and Gale, R., Skin adhesives and skin adhesion 1. Transdermal drug delivery systems. Biomaterials, 19, 1119-1136 (1998).
80. Villarino, N. and Landoni, M. F., Transdermal drug delivery: A new frontier in the administration of therapeutic drugs to veterinary species. Vet. J., 172, 200-201 (2006).
81. Walters, K. A., Walker, M., and Olejnik, O., Non-ionic surfactant effects on hairless mouse skin permeability characteristics. J. Pharm. Pharmacol., 40, 525-529 (1988).
82. Wokovich, A. M., Prodduturi, S., Doub, W. H., Hussain, A. S., and Buhse, L. F., Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur. J. Pharm. Biopharm., 64, 1-8 (2006).
83. Wolff, H.-M., Optimal process design for the manufacture of transdermal drug delivery systems. PSTT, 3, 173-181 (2000).
84. Yang, J., Lu, Y.-Y., and Kropp, J. E., Non-whitening emulsion pressure sensitive adhesives. US Patent 6, 013, 722 (2000).
85. Zhao, L., Li, Y., Fang, L., He, Z., Liu, X., Wang, L., Xu, Y., and Ren, C., Transdermal deilvery of tolterodine by Oacylmethol: In vitro/in vivo correlation. Int. J. Pharm., 374, 73-81 (2009).